A detailed history of Goldman Sachs Group Inc transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Goldman Sachs Group Inc holds 38,876 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,876
Previous 87,701 55.67%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
N/A
-48,825 Reduced 55.67%
38,876 $0
Q1 2024

May 15, 2024

BUY
N/A
54,106 Added 161.05%
87,701 $0
Q4 2023

Feb 13, 2024

BUY
N/A
22,558 Added 204.39%
33,595 $0
Q3 2023

May 14, 2024

SELL
N/A
-22,558 Reduced 67.15%
11,037 $0
Q3 2023

Nov 14, 2023

SELL
N/A
-34,199 Reduced 75.6%
11,037 $0
Q2 2023

May 14, 2024

SELL
N/A
-29,564 Reduced 39.52%
45,236 $0
Q2 2023

Aug 14, 2023

SELL
N/A
-29,564 Reduced 39.52%
45,236 $0
Q1 2023

May 14, 2024

BUY
N/A
6,422 Added 9.39%
74,800 $0
Q1 2023

May 11, 2023

BUY
N/A
6,422 Added 9.39%
74,800 $0
Q4 2022

May 14, 2024

SELL
$0.0 - $9.95 $0 - $134,713
-13,539 Reduced 16.53%
68,378 $0
Q4 2022

Feb 13, 2023

SELL
$0.0 - $9.95 $0 - $134,713
-13,539 Reduced 16.53%
68,378 $0
Q3 2022

May 14, 2024

BUY
$8.57 - $11.57 $26,901 - $36,318
3,139 Added 3.98%
81,917 $728,000
Q3 2022

Nov 10, 2022

BUY
$8.57 - $11.57 $26,901 - $36,318
3,139 Added 3.98%
81,917 $728,000
Q2 2022

May 14, 2024

BUY
$8.84 - $11.64 $399,417 - $525,930
45,183 Added 134.49%
78,778 $785,000
Q2 2022

Aug 15, 2022

SELL
$8.84 - $11.64 $82,105 - $108,112
-9,288 Reduced 10.55%
78,778 $785,000
Q1 2022

May 16, 2022

SELL
$10.07 - $11.93 $97,769 - $115,828
-9,709 Reduced 9.93%
88,066 $1.02 Million
Q4 2021

Feb 14, 2022

BUY
$7.95 - $11.24 $486,126 - $687,303
61,148 Added 166.95%
97,775 $1.09 Million
Q3 2021

Nov 10, 2021

BUY
$9.22 - $12.44 $337,700 - $455,639
36,627 New
36,627 $338,000

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.